Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
Scand J Rheumatol ; 27(6): 425-30, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9855212

RESUMO

This study is a comparison of treatments of idiopathic "Frozen Shoulder" (adhesive capsulitis), distension combined with steroid is compared with steroid alone. Evaluation was based on pain scales, analgesic usage, and range of motion outcome scales. Out of one-hundred twenty patients (age, mean 51, range 21-70) that were referred under the diagnosis FS, twenty-six fulfilled the criteria for inclusion in the study, but four patients did not want to participate in the trial, giving a total of 22 patients (age, mean 53, range 40-65) in the study. Patients were randomised by the envelope method. Two patients dropped-out, one in each treatment group thus leaving the study with 20 patients for the final statistical analysis. Eight were treated with steroid alone and 12 with distension combined with steroid. Patients received one treatment per week for a six weeks period with a follow-up at 12 weeks. They were evaluated by pain VAS on function and at rest within the study period, the different ranges of motion (ROM) were measured at inclusion time and subsequent afterwards at 3, 6, and 12 weeks. The VAS outcomes showed no difference between the treatments (VAS-function p=0,1; VAS-rest p=0.1), while in the distension group ROM showed significant improvement in all directions except extension (external p=0.0007, flexion p=0.03, extension p=0,01). The analgesic usage was significantly lower in the group treated with distension at the end of the study (p=0.008). A blinded clinical assessment of ROM also showed significant improvement (p=0.002). It is concluded that distension with steroid can seem to help in management of "Frozen Shoulder". Other studies seems to support the conclusion.


Assuntos
Anti-Inflamatórios/uso terapêutico , Bursite/terapia , Modalidades de Fisioterapia , Articulação do Ombro , Triancinolona Acetonida/análogos & derivados , Adulto , Idoso , Anti-Inflamatórios/administração & dosagem , Bursite/diagnóstico por imagem , Terapia Combinada , Feminino , Humanos , Injeções Intra-Articulares , Masculino , Pessoa de Meia-Idade , Medição da Dor , Amplitude de Movimento Articular , Articulação do Ombro/diagnóstico por imagem , Resultado do Tratamento , Triancinolona Acetonida/administração & dosagem , Triancinolona Acetonida/uso terapêutico , Ultrassonografia
4.
Wound Repair Regen ; 6(2): 121-6, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9776854

RESUMO

We reviewed all articles on ultrasound therapy published since 1950 to assess the evidence for an effect of this therapy in the treatment of chronic leg ulcers. Fourteen studies concerning ultrasound therapy, chronic leg ulcers, and wound healing were found. The six studies that fulfilled inclusion criteria for a randomized controlled trial were generally found lacking with respect to description of ulcer etiology-treated area, ultrasound head area, control of ultrasound apparatus, sham ultrasound apparatus, and follow-up evaluations. However, all six studies presented their data in a way that made pooling possible with respect to a decrease in ulcer area as a percent of the starting area. A standardized effect size was applied and gave evidence for a significant effect of ultrasound, showing a 16.9% (CI95: 6.3% to 27.5%, p = 0.011) mean difference in healing after 4 weeks of treatment and a 14.5% (CI95: 6.6% to 22.3%, p = 0.005) mean difference after 8 weeks of treatment compared with control treatment. In three studies, the number of healed ulcers was assessed, and pooling showed a nonsignificant (p = 0.06) therapeutic gain of 15% (CI95: 1% to 30%). This analysis would suggest that ultrasound has the best effect being delivered in low doses around the edge of the ulcer, but further studies are required to confirm this possible effect and to evaluate a possible dose-response relationship.


Assuntos
Úlcera da Perna/terapia , Terapia por Ultrassom , Idoso , Animais , Doença Crônica , Intervalos de Confiança , Ensaios Clínicos Controlados como Assunto , Feminino , Humanos , Úlcera da Perna/fisiopatologia , Masculino , Pessoa de Meia-Idade , Prognóstico , Fatores de Tempo , Resultado do Tratamento , Cicatrização/fisiologia
5.
Scand J Rheumatol ; 21(3): 139-41, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1604252

RESUMO

In a controlled, cross-over study the effect of low level laser therapy (LLLT) was evaluated. During a five weeks period forty-seven female laboratory technicians received six laser and six placebo treatments to tender points in the neck and shoulder girdle. Subjects rated the placebo treatment significantly more beneficial than LLLT (p = .04). There was no reduction in consumption of analgesics associated with either laser or placebo treatment. The results indicate no beneficial effect of LLLT for myofascial pain.


Assuntos
Terapia a Laser , Síndromes da Dor Miofascial/radioterapia , Adolescente , Adulto , Idoso , Método Duplo-Cego , Feminino , Humanos , Pessoa de Meia-Idade , Síndromes da Dor Miofascial/patologia , Músculos do Pescoço/patologia , Ombro/patologia
6.
Ugeskr Laeger ; 153(25): 1801-4, 1991 Jun 17.
Artigo em Dinamarquês | MEDLINE | ID: mdl-1853462

RESUMO

The effect of low-level laser therapy (GaAlAs, 830 nm, continuous) for chronic myofascial pain in the neck and shoulder girdle was assessed in a double-blind randomized study with 36 female participants. Treatments were given six times during two weeks with a total effect of 4.5-22.5 J per treatment depending on the number of tender points. No significant effect was found, neither in pain relief nor in tablet intake between the laser and the placebo group. None of the participants reported any side-effects.


Assuntos
Fibromialgia/radioterapia , Terapia a Laser , Músculos do Pescoço/efeitos da radiação , Ombro/efeitos da radiação , Adulto , Método Duplo-Cego , Feminino , Fibromialgia/diagnóstico , Humanos , Pessoa de Meia-Idade
7.
J Endocrinol Invest ; 14(6): 451-5, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1774441

RESUMO

The statement that pituitary hyperthyroidism reflects peripheral hyperthyroidism is still controversial. To evaluate a possible relationship between the calcium and the thyroid metabolism, 29 women with thyroxine (T4) substituted hypothyroidism were examined. They were separated into two groups, one with normal (0.15 to 6 mU/l) and one with suppressed TSH (less than 0.15 mU/l). All the women were judged euthyroid both by their T4 and T3 and by their clinics. The daily dose of T4 (median 0.15 mg in both groups) had been unchanged and TSH level had been stable during the previous six months. Bone mineral content (BMC) of the lumbar spine, bone mineral density (BMD) of left and right collum femoris, serum alkaline phosphatase activity (AP), serum concentration of osteocalcin (Ost) and urinary excretion of hydroxyproline/creatine (Hpr/crea) were similar in the two groups. Furthermore, sex- hormone-binding-globulin (SHBG) was equal in the two groups, but significantly higher than in normals (p less than 0.01). A significant positive correlation was found between serum Ost and Hpr/crea (p less than 0.05) indicating a balanced state where bone formation equals bone resorption. AP failed to correlate to Ost and Hpr/crea because the AP raises from both bone and liver of bone and liver metabolism whereas the two others predominantly reflect bone metabolism. SHBG, being a marker of liver metabolism, was elevated in both groups, probably because of the oral administration of T4. Our data suggest that euthyroid, T4 substituted patients have a normal calcium metabolism whether TSH levels are suppressed or not.


Assuntos
Osso e Ossos/metabolismo , Tireotropina/sangue , Tiroxina/farmacologia , Idoso , Fosfatase Alcalina/sangue , Densidade Óssea/efeitos dos fármacos , Osso e Ossos/efeitos dos fármacos , Cálcio/sangue , Cálcio/urina , Creatinina/sangue , Feminino , Humanos , Hidroxiprolina/urina , Fígado/metabolismo , Pessoa de Meia-Idade , Osteocalcina/sangue , Fosfatos/sangue , Globulina de Ligação a Hormônio Sexual/análise , Tri-Iodotironina/sangue
8.
Ugeskr Laeger ; 151(28): 1800-2, 1989 Jul 10.
Artigo em Dinamarquês | MEDLINE | ID: mdl-2773082

RESUMO

The present knowledge concerning bronchial carcinoid tumour (BCT) of the lung is described on the basis of two case histories. BCT belongs to the group of APUD tumours which are better known in the intestine. Patients with BCT are younger than patients with malignant pulmonary tumours. The incidence is less than 6% of all pulmonary tumours. The symptoms are similar to those of malignant pulmonary tumours but the duration is longer. The carcinoid syndrome is rare. It is frequently difficult to differentiate between BCT and small cell carcinoma. Radical surgery is indicated on account of the potential malignancy of BCT. The relapse frequency is less than 5% over a period of five years.


Assuntos
Neoplasias Brônquicas/diagnóstico , Tumor Carcinoide/diagnóstico , Adulto , Neoplasias Brônquicas/metabolismo , Neoplasias Brônquicas/cirurgia , Tumor Carcinoide/metabolismo , Tumor Carcinoide/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...